Collision tumor of colonic adenocarcinoma and EBV-driven large B-cell lymphoma: A case report and review of literature

Justin R. Yu , Qin Huang , Ping Hou , Jin-Ping Lai
{"title":"Collision tumor of colonic adenocarcinoma and EBV-driven large B-cell lymphoma: A case report and review of literature","authors":"Justin R. Yu ,&nbsp;Qin Huang ,&nbsp;Ping Hou ,&nbsp;Jin-Ping Lai","doi":"10.1016/j.ctrc.2014.12.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Collision tumors of adenocarcinoma and lymphoma in the gastrointestinal tract are especially rare with few reported cases in literature. We report a unique case of a collision tumor and perform a literature review.</p></div><div><h3>Presentation of case</h3><p>An 86-year-old patient with a history of rheumatoid arthritis on chronic azathioprine and prednisone was found to have an invasive adenocarcinoma in the descending colon. A large atypical lymphocytic infiltrate was found at the base of this lesion, which demonstrated CD20, lambda and EBER positivity consistent with adenocarcinoma colliding with EBV-driven and lambda-restricted large B-cell lymphoma.</p></div><div><h3>Discussion</h3><p>With this report, there are now fifteen cases of this type of collision tumor although the true incidence may be higher. Our case is unique among previous reports as the collision developed within the setting of iatrogenic immunosuppression and tumor EBV positivity was demonstrated. The pathogenesis is unknown, and diagnosis requires a high-degree of suspicion.</p></div><div><h3>Conclusion</h3><p>It is important to consider immunosuppression in a patient with adenocarcinoma, as presence of atypical lymphoid cells may be indicative of lymphoma.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2014.12.002","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089614000164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Introduction

Collision tumors of adenocarcinoma and lymphoma in the gastrointestinal tract are especially rare with few reported cases in literature. We report a unique case of a collision tumor and perform a literature review.

Presentation of case

An 86-year-old patient with a history of rheumatoid arthritis on chronic azathioprine and prednisone was found to have an invasive adenocarcinoma in the descending colon. A large atypical lymphocytic infiltrate was found at the base of this lesion, which demonstrated CD20, lambda and EBER positivity consistent with adenocarcinoma colliding with EBV-driven and lambda-restricted large B-cell lymphoma.

Discussion

With this report, there are now fifteen cases of this type of collision tumor although the true incidence may be higher. Our case is unique among previous reports as the collision developed within the setting of iatrogenic immunosuppression and tumor EBV positivity was demonstrated. The pathogenesis is unknown, and diagnosis requires a high-degree of suspicion.

Conclusion

It is important to consider immunosuppression in a patient with adenocarcinoma, as presence of atypical lymphoid cells may be indicative of lymphoma.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结肠腺癌与ebv驱动的大b细胞淋巴瘤碰撞瘤1例报告及文献复习
胃肠道腺癌和淋巴瘤的碰撞肿瘤尤其罕见,文献报道病例很少。我们报告一个独特的碰撞肿瘤病例,并进行文献复习。病例介绍一位86岁的类风湿关节炎患者,长期服用硫唑嘌呤和强的松,在降结肠发现浸润性腺癌。在病灶底部发现一个大的非典型淋巴细胞浸润,CD20, lambda和EBER阳性,与腺癌与ebv驱动和lambda限制性大b细胞淋巴瘤碰撞一致。尽管真实的发病率可能更高,但根据本报告,目前有15例这种类型的碰撞瘤。我们的病例在以前的报告中是独特的,因为碰撞发生在医源性免疫抑制和肿瘤EBV阳性的背景下。发病机制尚不清楚,诊断需要高度怀疑。结论腺癌患者应考虑免疫抑制,因为非典型淋巴样细胞的存在可能预示着淋巴瘤的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series Pigmentation of the tongue with lapatinib treatment in a patient with advanced breast cancer: A case report Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study Multiple nodular lung metastases with no obvious primary showing low positive 18-fluoro deoxyglucose (FDG) uptake on positron emission tomography (PET) scan: A unique case of metastatic ameloblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1